Herpes simplex virus vectors for gene therapy in Parkinson's disease and other diseases of the nervous system

French Anderson W. Human gene therapy. Nature 1998; 392(suppl): 25–30.

Haase G , Kennel P , Pettmann B Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors. Nature Med 1997; 3: 429–36.

Latchman DS. Heat shock proteins: protective effect and potential therapeutic use. Int J Molec Med 1998; 2: 375–81.

Lindvall O , Brundin P , Widner H Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 1996; 247: 574–77.

Bencsjcs C , Wachtel SR , Milstien S Double transduction with GTP cyclohydrolase I and tyrosine hydroxylase is necessary for spontaneous synthesis of L-DOPA by primary fibroblasts. J Neurosci 1996; 16: 4449–56.

Lapchak PA , Miller PJ , Jiao SS , Araujo DM , Hilt D , Collins R. Biology of glial cell line-derived neurotrophic factor (GDNF): implications for the use of GDNF to treat Parkinson's disease. Neurodegeneration 1996; 5: 197–205.

Lapchak PA. Therapeutic potentials for glial cell line-derived neurotrophic factor (GDNF) based upon pharmacological activities in the CNS. Rev Neurosci 1996; 7: 165–76.

Latchman DS ed. Genetic Manipulation of the Nervous System. London: Academic Press, 1996.

Fisher LJ , Jinnah HA , Kale LC , Higgins GA , Gage FH. Survival and function of intrastriatally grafted primary fibroblasts genetically modified to produce L-dopa. Neuron 1991; 6: 371–80.

Senut M-C , Suhr ST , Gage FH. Transplantation of genetically modified non-neuronal cells in the central nervous system. In: Latchman DS ed. Genetic Manipulation of the Nervous System. London: Academic Press, 1996: 181–202.

Tsuda M , Imaokea T. Direct injection of plasmid DNA into the brain. In: Latchman DS ed. Genetic Manipulation of the Nervous System. London: Academic Press, 1996: 235–48.

Horellou P , Vigne E , Castel MN Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease. NeuroReport 1994; 6: 49–53.

Kaplitt MG , Leone P , Samulski RJ Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nature Genet 1994; 8: 148–54.

During MJ , Naegele JR , O'Malley KL , Geller AI. Long-term behavioural recovery in parkinsonian rats by an HSV vector expressing tyrosine hydoxylase. Science 1994; 266: 1399–403.

Latchman DS. Molecular biology of herpes simplex virus latency. Int J Exp Pathol 1990; 71: 133–41.

Fink DJ , DeLuca NA , Goins WF , Giorioso JC. Gene transfer to neurons using herpes simplex virus-based vectors. Ann Rev Neurosci 1996; 19: 265–87.

Coffin RS , Latchman DS. Herpes simplex virus based vectors. In: Latchman DS ed. Genetic Manipulation of the Nervous System. London: Academic Press, 1996: 99–114.

Dobson AT , Margolis TP , Sedarati F , Stevens JG , Feldman LT. A latent nonpathogenic HSV-1 derived vector stably expresses β galactosidase in mouse neurons. Neuron 1990; 5: 353–60.

Howard MK , Kershaw T , Gibb B High efficiency gene transfer to the central nervous system of rodents and primates using herpes virus vectors lacking functional ICP27 and ICP34.5. Gene Ther 1998; 5: 1137–47.

Maclean AR , Fareed MU , Robertson L , Harland J , Brown SM. Herpes simplex virus type 1 deletion variants 1714 and 1716 pinpoint neuro virulence related sequences in Glasgow strain 17+ between immediate-early gene 1 and the ‘a’ sequence. J Gen Virol 1991; 72: 631–9.

Coffin RS , Maclean AR , Latchman DS , Brown SM. Gene delivery to the central and peripheral nervous systems of mice using HSV1 ICP34.5 deletion mutant vectors. Gene Ther 1996; 3: 886–91.

Wang Q , Guo J , Jia W. Intracerebral recombinant HSV-1 vector does not reactivate latent HSV-1. Gene Ther 1997; 4: 1300–4.

Rampling R , Cruickshank G , Maclean AR , Brown SM. Therapeutic replication competent herpes virus. Nature Med 1999; 2: 133.

Wagstaff MJD , Collaco-Moraes Y , Smith J , de Belleroche J , Coffin RS , Latchman DS. Protection of neuronal cells from apoptosis by hsp27 delivered with a herpes simplex virus-based vector. J Biol Chem 1999; 274: 5061–9.

Smith MD , Ensor EA , Coffin RS , Boxer LM , Latchman DS. Bel-2 transcription from the proximal p2 promoter is activated in neuronal cells by the Brn-3a POU family transciption factor. J Biol Chemistry 1998; 273: 16715–22.